Brinker Capital Investments, LLC Viatris Inc Transaction History

Brinker Capital Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	SELL	$9.95 - $12.27 $1.42 Million - $1.75 Million	-142,256 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$9.81 - $15.4 $397,638 - $624,223	-40,534 Reduced 22.18%	142,256 $1.55 Million
Q4 2021 Feb 08, 2022	SELL	$12.09 - $14.68 $314,303 - $381,635	-25,997 Reduced 12.45%	182,790 $2.47 Million
Q2 2021 Aug 03, 2021	BUY	$12.97 - $16.15 $641,703 - $799,037	49,476 Added 31.06%	208,787 $2.98 Million
Q1 2021 May 12, 2021	SELL	$13.59 - $18.54 $1.04 Million - $1.42 Million	-76,332 Reduced 32.39%	159,311 $2.23 Million
Q4 2020 Feb 16, 2021	BUY	$14.3 - $18.74 $3.37 Million - $4.42 Million	235,643 New	235,643 $4.42 Million

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Brinker Capital Investments, LLC with notifications on news.